Skip to main content
Top
Published in: Drugs & Aging 3/2016

01-03-2016 | Review Article

Optimization of Geriatric Pharmacotherapy: Role of Multifaceted Cooperation in the Hospital Setting

Authors: Mirko Petrovic, Annemie Somers, Graziano Onder

Published in: Drugs & Aging | Issue 3/2016

Login to get access

Abstract

Because older patients are more vulnerable to adverse drug-related events, there is a need to ensure appropriate pharmacotherapy in these patients. This narrative review describes approaches to improve pharmacotherapy in older people in the hospital setting. Screening to identify older patients at risk of drug-related problems and adverse drug reactions (ADRs) is the first critical step within a multistep approach to geriatric pharmacotherapy. Two methods that have been developed are the GerontoNet ADR risk score and the Brighton Adverse Drug Reactions Risk (BADRI) model, which take into account a number of factors, the most important of which is the number of medicines. In order to reduce potentially inappropriate prescribing in older patients, different types of interventions exist, such as pharmacist-led medication reviews, educational interventions, computerized decision support systems, and comprehensive geriatric assessment. The effects of these interventions have been studied, sometimes in a multifaceted approach, by combining different techniques. None of the existing interventions shows a clear beneficial effect on patients’ health outcomes if applied in isolation; however, when these interventions are combined within the context of a multidisciplinary team, positive effects on patients’ health outcomes can be expected. Appropriate geriatric pharmacotherapy, global assessment of patients’ clinical and functional parameters, and integration of skills from different healthcare professionals are needed to address medical complexity of older adults.
Literature
1.
go back to reference Passarelli M, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22:767–77.CrossRefPubMed Passarelli M, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22:767–77.CrossRefPubMed
2.
go back to reference Batty G, Grant R, Aggarwal R, Lowe D, Potter J, Pearson M, et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing. 2003;32:292–8.CrossRefPubMed Batty G, Grant R, Aggarwal R, Lowe D, Potter J, Pearson M, et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing. 2003;32:292–8.CrossRefPubMed
3.
go back to reference Hanlon J, Artz M, Pieper C, Lindblad C, Sloane R, Ruby C, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38:9–14.CrossRefPubMed Hanlon J, Artz M, Pieper C, Lindblad C, Sloane R, Ruby C, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004;38:9–14.CrossRefPubMed
4.
go back to reference Classen D, Pestotnik S, Evans R, Lloyd J, Burke J. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–6.CrossRefPubMed Classen D, Pestotnik S, Evans R, Lloyd J, Burke J. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–6.CrossRefPubMed
5.
go back to reference Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.CrossRefPubMed Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.CrossRefPubMed
6.
go back to reference Jha A, Kuperman G, Teich J, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998;5:305–14.CrossRefPubMedPubMedCentral Jha A, Kuperman G, Teich J, Leape L, Shea B, Rittenberg E, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998;5:305–14.CrossRefPubMedPubMedCentral
7.
go back to reference Eland I, Belton K, van Grootheest A, Meiners A, Rawlins M, Stricker B. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623–7.CrossRefPubMedPubMedCentral Eland I, Belton K, van Grootheest A, Meiners A, Rawlins M, Stricker B. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48:623–7.CrossRefPubMedPubMedCentral
8.
go back to reference Beijer H, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.CrossRefPubMed Beijer H, de Blaey C. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24:46–54.CrossRefPubMed
9.
go back to reference Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T, Farrar K, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.CrossRefPubMedPubMedCentral Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T, Farrar K, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.CrossRefPubMedPubMedCentral
10.
go back to reference Lindley C, Tully M, Paramsothy V, Tallis R. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992;21:294–300.CrossRefPubMed Lindley C, Tully M, Paramsothy V, Tallis R. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992;21:294–300.CrossRefPubMed
11.
go back to reference Leendertse A, Egberts A, Stoker L, van den Bemt P, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed Leendertse A, Egberts A, Stoker L, van den Bemt P, HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168:1890–6.PubMed
12.
go back to reference van den Bemt P, Egberts A, Lenderink A, Verzijl J, Simons K, van der Pol W, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci. 2000;22:62–6.CrossRefPubMed van den Bemt P, Egberts A, Lenderink A, Verzijl J, Simons K, van der Pol W, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci. 2000;22:62–6.CrossRefPubMed
13.
go back to reference Hajjar E, Hanlon J, Artz M, Lindblad C, Pieper C, Sloane R, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1:82–9.CrossRefPubMed Hajjar E, Hanlon J, Artz M, Lindblad C, Pieper C, Sloane R, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother. 2003;1:82–9.CrossRefPubMed
14.
go back to reference Field T, Gurwitz J, Avorn J, McCormick D, Jain S, Eckler M, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;61:1629–34.CrossRef Field T, Gurwitz J, Avorn J, McCormick D, Jain S, Eckler M, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;61:1629–34.CrossRef
15.
go back to reference Field T, Gurwitz J, Harrold L, Rothschild J, Debellis K, Seger A, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349–54.CrossRefPubMed Field T, Gurwitz J, Harrold L, Rothschild J, Debellis K, Seger A, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349–54.CrossRefPubMed
16.
go back to reference Lund B, Carnahan R, Egge J, Chrischilles E, Kaboli P. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957–63.CrossRefPubMed Lund B, Carnahan R, Egge J, Chrischilles E, Kaboli P. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44:957–63.CrossRefPubMed
17.
go back to reference Steinman M, Landefeld C, Rosenthal G, Berthenthal D, Sen S, Kaboli P. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.CrossRefPubMed Steinman M, Landefeld C, Rosenthal G, Berthenthal D, Sen S, Kaboli P. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:1516–23.CrossRefPubMed
18.
go back to reference Page R, Linnebur S, Bryant L, Ruscin J. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentral Page R, Linnebur S, Bryant L, Ruscin J. Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging. 2010;5:75–87.CrossRefPubMedPubMedCentral
20.
go back to reference Schwartz J. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther. 2007;82:87–96.CrossRefPubMed Schwartz J. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther. 2007;82:87–96.CrossRefPubMed
21.
go back to reference Le Couteur D, Hilmer S, Glasgow N, Naganathan V, Cumming R. Prescribing in older people. Aust Fam Physician. 2004;33:777–81.PubMed Le Couteur D, Hilmer S, Glasgow N, Naganathan V, Cumming R. Prescribing in older people. Aust Fam Physician. 2004;33:777–81.PubMed
22.
go back to reference Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171:550–6.CrossRefPubMed Cherubini A, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171:550–6.CrossRefPubMed
24.
go back to reference Onder G, Petrovic M, Tangiisuran B, Meinardi M, Markito-Notenboom W, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170:1142–8.CrossRefPubMed Onder G, Petrovic M, Tangiisuran B, Meinardi M, Markito-Notenboom W, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170:1142–8.CrossRefPubMed
25.
go back to reference O’Connor M, Gallagher P, Byrne S, O’Mahony D. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41:771–6.CrossRefPubMed O’Connor M, Gallagher P, Byrne S, O’Mahony D. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41:771–6.CrossRefPubMed
26.
go back to reference Tangiisuran B, Scutt G, Stevenson J, Wright J, Onder G, Petrovic M, et al. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model. PLOS One. 2014;9:e111254.CrossRefPubMedPubMedCentral Tangiisuran B, Scutt G, Stevenson J, Wright J, Onder G, Petrovic M, et al. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model. PLOS One. 2014;9:e111254.CrossRefPubMedPubMedCentral
27.
go back to reference Hilmer S, Mager D, Simonsick E, Cao Y, Ling S, Windham B, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781.CrossRefPubMed Hilmer S, Mager D, Simonsick E, Cao Y, Ling S, Windham B, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781.CrossRefPubMed
28.
go back to reference Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.CrossRefPubMed Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.CrossRefPubMed
29.
go back to reference Berenguer B, La Casa C, de la Matta M, Martín-Calero M. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004;10:3931–46.CrossRefPubMed Berenguer B, La Casa C, de la Matta M, Martín-Calero M. Pharmaceutical care: past, present and future. Curr Pharm Des. 2004;10:3931–46.CrossRefPubMed
30.
go back to reference Cipolle R, Strand L, Morley P. Pharmaceutical care practice. New York: Mc Graw Hill; 1998. Cipolle R, Strand L, Morley P. Pharmaceutical care practice. New York: Mc Graw Hill; 1998.
32.
go back to reference Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29:495–510.CrossRefPubMed Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29:495–510.CrossRefPubMed
33.
go back to reference Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S, et al; for the PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157:1–10. Kripalani S, Roumie C, Dalal A, Cawthon C, Businger A, Eden S, et al; for the PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157:1–10.
34.
go back to reference Spinewine A, Swine C, Dhillon S, Lambert P, Nachega J, Wilmotte L, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55:658–65.CrossRefPubMed Spinewine A, Swine C, Dhillon S, Lambert P, Nachega J, Wilmotte L, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55:658–65.CrossRefPubMed
35.
go back to reference Chisholm-Burns M, Kim Lee J, Spivey C, Slack M, Herrier R, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.CrossRefPubMed Chisholm-Burns M, Kim Lee J, Spivey C, Slack M, Herrier R, Hall-Lipsy E, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.CrossRefPubMed
36.
go back to reference Klopotowska J, Kuiper R, van Kan H, de Pont A, Dijkgraaf M, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.CrossRefPubMedPubMedCentral Klopotowska J, Kuiper R, van Kan H, de Pont A, Dijkgraaf M, Lie-A-Huen L, et al. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Crit Care. 2010;14:R174.CrossRefPubMedPubMedCentral
37.
go back to reference Schnipper J, Hamann C, Ndumele C, Liang C, Carty M, Karson A, Bhan I, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169:771–80.CrossRefPubMed Schnipper J, Hamann C, Ndumele C, Liang C, Carty M, Karson A, Bhan I, et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: a cluster-randomized trial. Arch Intern Med. 2009;169:771–80.CrossRefPubMed
38.
go back to reference Kucukarslan S, Peters M, Mlynarek M, Nafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRefPubMed Kucukarslan S, Peters M, Mlynarek M, Nafziger D. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163:2014–8.CrossRefPubMed
39.
go back to reference Leape L, Cullen D, Clapp M, Burdick E, Demonaco H, Erickson J, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed Leape L, Cullen D, Clapp M, Burdick E, Demonaco H, Erickson J, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267–70.CrossRefPubMed
40.
go back to reference Ross S, Loke Y. Do educational interventions improve prescribing by medical students and junior doctors? A systematic review. Br J Clin Pharmacol. 2009;67:662–70.CrossRefPubMedPubMedCentral Ross S, Loke Y. Do educational interventions improve prescribing by medical students and junior doctors? A systematic review. Br J Clin Pharmacol. 2009;67:662–70.CrossRefPubMedPubMedCentral
41.
go back to reference Spinewine A, Schmader K, Barber N, Hughes C, Lapane K, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.CrossRefPubMed Spinewine A, Schmader K, Barber N, Hughes C, Lapane K, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–84.CrossRefPubMed
42.
go back to reference Loganathan M, Singh S, Franklin B, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40:150–62.CrossRefPubMed Loganathan M, Singh S, Franklin B, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40:150–62.CrossRefPubMed
43.
go back to reference McLeod P, Huang A, Tamblyn R, Gayton D. Defining inappropriate practices in, prescribing for elderly people: a national consensus panel. Can Med Assoc J. 1997;456:385–91. McLeod P, Huang A, Tamblyn R, Gayton D. Defining inappropriate practices in, prescribing for elderly people: a national consensus panel. Can Med Assoc J. 1997;456:385–91.
44.
go back to reference Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642–6.CrossRefPubMed Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642–6.CrossRefPubMed
45.
go back to reference Naugler C, Brymer C, Stolee P, Arcese Z. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103–7.PubMed Naugler C, Brymer C, Stolee P, Arcese Z. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7:103–7.PubMed
46.
go back to reference Zhan C, Sangl J, Bierman A, Miller M, Friedman B, Wickizer S, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the1996 Medical Expenditure Panel Survey. JAMA. 2001;286:2823–9.CrossRefPubMed Zhan C, Sangl J, Bierman A, Miller M, Friedman B, Wickizer S, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the1996 Medical Expenditure Panel Survey. JAMA. 2001;286:2823–9.CrossRefPubMed
47.
go back to reference Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Grégoire J. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.CrossRefPubMedPubMedCentral Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Grégoire J. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.CrossRefPubMedPubMedCentral
48.
go back to reference Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31.CrossRefPubMed Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–31.CrossRefPubMed
49.
go back to reference Basger B, Chen T, Moles R. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25:777–93.CrossRefPubMed Basger B, Chen T, Moles R. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25:777–93.CrossRefPubMed
50.
go back to reference Basger B, Chen T, Moles R. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open. 2012;2(5):e001431.CrossRefPubMedPubMedCentral Basger B, Chen T, Moles R. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open. 2012;2(5):e001431.CrossRefPubMedPubMedCentral
51.
go back to reference Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr. 2008;47:35–51.CrossRefPubMed Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr. 2008;47:35–51.CrossRefPubMed
52.
go back to reference Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller T, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.CrossRefPubMedPubMedCentral Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller T, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care. 2009;27:153–9.CrossRefPubMedPubMedCentral
53.
go back to reference Holt S, Schmiedl S, Thurmann P. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.PubMedPubMedCentral Holt S, Schmiedl S, Thurmann P. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.PubMedPubMedCentral
54.
go back to reference Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32.CrossRefPubMed Beers M, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151:1825–32.CrossRefPubMed
55.
go back to reference American Geriatrics Society. Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;2012(60):616–31. American Geriatrics Society. Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;2012(60):616–31.
56.
go back to reference Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.CrossRefPubMed Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46:72–83.CrossRefPubMed
57.
go back to reference O’Mahony, O’Sullivan D, Byrne S, O’Connor M, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8. O’Mahony, O’Sullivan D, Byrne S, O’Connor M, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.
58.
go back to reference Gallagher P, O’Connor M, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845–54.CrossRefPubMed Gallagher P, O’Connor M, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89:845–54.CrossRefPubMed
59.
go back to reference Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171:1013–9.CrossRefPubMed Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171:1013–9.CrossRefPubMed
60.
go back to reference Hanlon J, Schmader K, Samsa G, Weinberger M, Uttech K, Lewis I, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRefPubMed Hanlon J, Schmader K, Samsa G, Weinberger M, Uttech K, Lewis I, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045–51.CrossRefPubMed
61.
go back to reference Verduijn M, Leendertse A, Moeselaar A, De Wit N, Van Marum R. Multidisciplinaire richtlijn Polyfarmacie bij ouderen. Huisarts Wet 2013;56:414–9.CrossRef Verduijn M, Leendertse A, Moeselaar A, De Wit N, Van Marum R. Multidisciplinaire richtlijn Polyfarmacie bij ouderen. Huisarts Wet 2013;56:414–9.CrossRef
62.
go back to reference Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701. Drenth-van Maanen AC, van Marum RJ, Knol W, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701.
63.
go back to reference Geurts MM, Talsma J, Brouwers JR, et al. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74:16–33.CrossRefPubMedPubMedCentral Geurts MM, Talsma J, Brouwers JR, et al. Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. Br J Clin Pharmacol. 2012;74:16–33.CrossRefPubMedPubMedCentral
64.
go back to reference Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008;23:451–8.CrossRefPubMedPubMedCentral Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008;23:451–8.CrossRefPubMedPubMedCentral
65.
go back to reference Strom B, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard C, et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med. 2010;170:1578–83.CrossRefPubMed Strom B, Schinnar R, Aberra F, Bilker W, Hennessy S, Leonard C, et al. Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. Arch Intern Med. 2010;170:1578–83.CrossRefPubMed
66.
go back to reference Tamblyn R, Eguale T, Buckeridge D, Huang A, Hanley J, Reidel K, et al. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial. J Am Med Inform Assoc. 2012;19:635–43.CrossRefPubMedPubMedCentral Tamblyn R, Eguale T, Buckeridge D, Huang A, Hanley J, Reidel K, et al. The effectiveness of a new generation of computerized drug alerts in reducing the risk of injury from drug side effects: a cluster randomized trial. J Am Med Inform Assoc. 2012;19:635–43.CrossRefPubMedPubMedCentral
67.
go back to reference Scullin C, Scott M, Hogg A, McElnay J. An innovative approach to integrated medicine management. J Eval Clin Pract. 2007;13:781–8.CrossRefPubMed Scullin C, Scott M, Hogg A, McElnay J. An innovative approach to integrated medicine management. J Eval Clin Pract. 2007;13:781–8.CrossRefPubMed
68.
go back to reference Ellis G, Whitehead M, Robinson D, O’Neill D, Langhorne P. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011;343:d6553.CrossRefPubMedPubMedCentral Ellis G, Whitehead M, Robinson D, O’Neill D, Langhorne P. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011;343:d6553.CrossRefPubMedPubMedCentral
69.
go back to reference Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29:453–62.CrossRefPubMed Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29:453–62.CrossRefPubMed
70.
go back to reference Onder G, van der Cammen T, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42:284–91.CrossRefPubMed Onder G, van der Cammen T, Petrovic M, Somers A, Rajkumar C. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42:284–91.CrossRefPubMed
71.
go back to reference Onder G, Lattanzio F, Battaglia M, Cerullo F, Sportiello R, Bernabei R, et al. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab. 2011;12:647–51.CrossRefPubMed Onder G, Lattanzio F, Battaglia M, Cerullo F, Sportiello R, Bernabei R, et al. The risk of adverse drug reactions in older patients: beyond drug metabolism. Curr Drug Metab. 2011;12:647–51.CrossRefPubMed
72.
go back to reference Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging. 2010;27:507–21.CrossRefPubMed Lampela P, Hartikainen S, Lavikainen P, Sulkava R, Huupponen R. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging. 2010;27:507–21.CrossRefPubMed
73.
go back to reference Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) project. Drugs Aging. 2014;31(1):33–45.CrossRefPubMed Onder G, Landi F, Fusco D, Corsonello A, Tosato M, Battaglia M, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) project. Drugs Aging. 2014;31(1):33–45.CrossRefPubMed
74.
go back to reference Schmader K, Hanlon J, Pieper C, Sloane R, Ruby C, Twersky J, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394–401.CrossRefPubMed Schmader K, Hanlon J, Pieper C, Sloane R, Ruby C, Twersky J, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394–401.CrossRefPubMed
Metadata
Title
Optimization of Geriatric Pharmacotherapy: Role of Multifaceted Cooperation in the Hospital Setting
Authors
Mirko Petrovic
Annemie Somers
Graziano Onder
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 3/2016
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-016-0352-7

Other articles of this Issue 3/2016

Drugs & Aging 3/2016 Go to the issue

Introduction

Introduction

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine